Clenbuterol vs Propranolol
Well Studied vs FDA Approved
monitor Researched · 90% Propranolol and clenbuterol have directly opposing mechanisms at the beta-2 receptor. Propranolol will antagonize clenbuterol's tachycardic effects (which is often the intent) but will also partially blunt its thermogenic and bronchodilatory activity. Use the lowest effective propranolol dose to manage heart rate without fully negating clenbuterol's desired effects. Never abruptly start high-dose propranolol while on clenbuterol, as the rapid shift in adrenergic tone can cause hemodynamic instability.
Molecular Data
Clenbuterol Propranolol
Weight 277.19 Da 259.34 Da
Half-life ~36 hours ~4-5 hours
Type Sympathomimetic amine (C12H18Cl2N2O) Aryloxypropanolamine derivative (C16H21NO2)
Key Benefits
Clenbuterol
01 Increased basal metabolic rate and thermogenesis for accelerated fat loss
02 Preferential mobilization of stored body fat through enhanced lipolysis
03 Anti-catabolic effects that help preserve lean muscle mass during caloric restriction
04 Bronchodilation and improved respiratory capacity during intense exercise
05 Appetite suppression in many users, supporting adherence to caloric deficit
06 Oral administration with no injections required
Propranolol
01 Rapid reduction of elevated heart rate within 30-60 minutes of oral dosing
02 Effective against tachycardia from both trenbolone and clenbuterol through non-selective beta blockade
03 Well-established anxiolytic effect for performance anxiety without cognitive impairment or sedation
04 Short half-life allows flexible as-needed dosing without prolonged hemodynamic effects
05 Extensive clinical safety data spanning over 50 years of use
06 Inexpensive and widely available as a generic medication
07 Does not cause dependence or withdrawal symptoms typical of benzodiazepines
08 Effective for controlling physical anxiety symptoms (tremor, palpitations, sweating)
Side Effects
Clenbuterol
Tremors and shaking (especially hands) - most pronounced in the first 3-5 days
Tachycardia (elevated heart rate, typically 10-20 bpm above baseline)
Insomnia and sleep disturbance, particularly with afternoon or evening dosing
Muscle cramps (calves, forearms, back) due to taurine depletion
Increased sweating and elevated body temperature
Headaches, particularly during dose ramp-up
Nervousness, anxiety, and restlessness
Increased blood pressure
Propranolol
Fatigue and reduced exercise tolerance, particularly during the first week of use
Cold extremities (hands and feet) due to beta-2 blockade of peripheral vasodilation
Bradycardia (heart rate below 60 bpm), usually dose-dependent and asymptomatic
Dizziness or lightheadedness, especially when standing quickly
Gastrointestinal discomfort (nausea, diarrhea, constipation)
Contraindications
Pre-existing cardiovascular disease, cardiomyopathy, or arrhythmia
Uncontrolled hypertension
Hyperthyroidism or thyrotoxicosis
Hypokalemia or electrolyte imbalances
Known hypersensitivity to clenbuterol or sympathomimetic amines
Concurrent use of other stimulants (ephedrine, amphetamines) or MAO inhibitors
Pregnancy or breastfeeding
Asthma or severe reactive airway disease (non-selective beta blockade can trigger life-threatening bronchospasm)
Decompensated heart failure or cardiogenic shock
Sinus bradycardia (resting HR below 50 bpm) or second/third-degree heart block
Severe peripheral arterial disease or Raynaud's syndrome
Pheochromocytoma without prior alpha blockade (risk of hypertensive crisis from unopposed alpha stimulation)
Research Evidence
Clenbuterol Propranolol
Status Well Studied FDA Approved
References 5 studies 5 studies
Latest 2021 2023
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.